Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5217-5222

  Opolski, Adam ^a   Wietrzyk, Joanna ^a   Chrobak, Agnieszka ^a   Marcinkowska, Ewa ^a   Wojdat, Elzbieta ^a   Kutner, Andrzej ^b   Radzikowski, Czesław ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

1,25 dihydroxyvitamin D3; Antiproliferative activity in vitro; Calcitriol and its analogues; Human cancer cell lines

Indexed keywords

CALCITRIOL DERIVATIVE; CD11B ANTIGEN; CD14 ANTIGEN; PRI 1906; PRI 1907; PRI 1909; PRI 2191; PRI 2192; PRI 2193; PRI 2194; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN MCF 7; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; KIDNEY CANCER; LEUKEMIA CELL LINE; LUNG CANCER; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SKIN FIBROBLAST; STOMACH CANCER;

ANTINEOPLASTIC AGENTS; CALCITRIOL; CELL DIVISION; CELL LINE; HL-60 CELLS; HUMANS;

EID: 0033395873     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Reichel H, Koeffler HP, Norman AW: The role of the vitamin D endocrine system in health and disease. N Engl J Med 320: 980-991, 1989.
2. 3-induced differentiation in a human promyelocytic leukemia cell line (HL 60): receptor mediated maturation to macrophage-like cells. J Cell Bioch 98: 391-398, 1984.
3. 3 receptor. Cancer Res 44: 2103-2109, 1984.
4. 3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 53: 3712-3718, 1993.
5. Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ, Evans SRT: Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat. 31: 191-202, 1994.
6. 3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture. Endocrinology 108: 1083-1086, 1981.
7. 3. Cancer Res 47: 21-25, 1987.
8. 3 prolong survival time of mice inoculated with myeloid leukaemia cells. Proc Natl Acad Sci USA 80: 201-204, 1983.
9. Colston KW, Berger U, Coombes RC: Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1: 188-191, 1989.
10. Cunningham D, Gilchrist NL, Cowan RA, Soukup K: Alpha-calcitriol as a modulator of growth of low-grade non-Hodgkin's lymphomas. Br Med J 291: 1153-1155, 1985.
11. Kelsey SM, Newland AC, Cunningham J, Makin HLJ, Coldwell RD, Mills MJ, Grant IR: Sustained hematological response to high-doses oral alphacalcidol in patients with myelodysplastic syndromes. Lancet 340: 316-317, 1992.
12. Pols HAP, Birkenhager JC, van Leeuwen JPTM: Vitamin D analogues: from molecule to clinical application. Clin Endocrinol (Oxf) 40: 285-291, 1994.
13. 3, a potent angiogenesis inhibitor, on rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene. Anti-Cancer Drugs 2: 475-480, 1991.
14. 3, and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RARα mediates the antiangiogenic effect of retinoids. Cancer Lett 89: 117-124, 1995.
15. Shokravi MR, Marcus DM, Alroy J, Egan K, Saornil MA, Albert DM: Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci 36: 83-87, 1995.
16. 3 inhibits the invasive potential of human breast cancer cells in vitro. Clin Exp Metastasis 12: 195-202, 1994.
17. 3 dimishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and reccurence. Cancer Immunol Immunother 41: 37-45, 1995.
18. Odrzywolska M, ChodyDski M, Fitak H, Zorgdrager J, Van de Velde J-P: Pol Pat P-329101, 1999 (submitted).
19. Gollnick H, Menke T: Current experience with Tacalcitol ointment in the treatment of psoriasis. Curr Med Res Opinion 14: 213-218, 1998.
20. 3 analogues: A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cells. Cancer Res 55: 2822-2830, 1995.
21. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Bioch Biophys Res Comm 241: 419-426, 1997.
22. Marcinkowska E, Wiedlocha A, Radzikowski C: Evidence that phosphatidylinositol 3-kinase and p70S6K protein are involved in differentiation of HL-60 cells induced by calcitriol. Anticancer Res 18: 3507-3514, 1998.
23. 3. J Steroid Biochem Molec Biol 67: 71-78, 1998.